- September 11, 2018
- Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical to Support the Pink Ribbon Campaign Again in 2018
In 2018, Taiho Pharmaceutical is once again supporting the Pink Ribbon campaign to promote a greater understanding of breast cancer and raise awareness of the importance of its early detection, diagnosis and treatment.
Every year during breast cancer awareness month in October, various events are held worldwide, including in Europe and the U.S. Among other initiatives, Taiho Pharmaceutical sponsors the annual Pink Ribbon Festival co-organized by the Japan Cancer Society.
The incidence of breast cancer is increasing in Japan. It is estimated that around 90,000 Japanese women developed breast cancer in 2017.*1 Taiho Pharmaceutical is continuing to provide information for patients on the website, All About Breast Cancer Info,*2 in order to promote early detection of breast cancer and to encourage patients to face breast cancer with optimism.
Taiho Pharmaceutical will continue striving to improve human health and contribute to a society enriched by smiles.
*1. Source: 2017 Statistics Predictions, Cancer Statistics, Cancer Information Service, National Cancer Center Japan
*2. All About Breast Cancer Info (in Japanese): http://nyugan.info/allabout/
About the Pink Ribbon Festival
This year will be the 16th year of the Pink Ribbon Festival, which has been carried out around Japan by the Japan Cancer Society and other organizations since 2003 to convey the importance of breast cancer exams and to support patients. It aims to increase the rate of breast cancer screening and to conduct activities that support patients and people around them so as to reduce the death rate from breast cancer as much as possible.
See here for details (in Japanese): http://www.pinkribbonfestival.jp/
Since 2007, Taiho Pharmaceutical has set up a booth at the Pink Ribbon Symposium where it provides visitors with pamphlets and other information to promote early detection of various cancers, including breast cancer.
This year Taiho Pharmaceutical will also co-sponsor the Pink Ribbon Seminar.
About Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical, a subsidiary of Otsuka Holdings Co., Ltd. (https://www.otsuka.com/en/), is an R&D-driven specialty pharma focusing on the three fields of oncology, allergy and immunology, and urology. Its corporate philosophy takes the form of a pledge: “We strive to improve human health and contribute to a society enriched by smiles.” In the field of oncology, in particular, Taiho Pharmaceutical is known as a leading company in Japan for developing innovative medicines for the treatment of cancer, a reputation that is rapidly expanding through their extensive global R&D efforts. In areas other than oncology, as well, the company creates and markets quality products that effectively treat medical conditions and can help improve people’s quality of life. Always putting customers first, Taiho Pharmaceutical also aims to offer consumer healthcare products that support people’s efforts to lead fulfilling and rewarding lives. For more information about Taiho Pharmaceutical, please visit https://www.taiho.co.jp/en/
-
-
- Illumination with LED lights in the shape of pink ribbons at the Kitajima Plant in Tokushima Prefecture during Pink Ribbon Month in October
-
-
-
- Encouraging awareness in and outside the company by providing information about Pink Ribbon tissues at the head office’s reception desk
-
Information in this news release was current as of the original release date.
Taiho Pharmaceutical's press releases may contain information about prescription drugs including products currently under development, however information contained in the press releases are not intended to constitute promotion, advertisement, or medical advice.